| Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole … JH Rex, MA Pfaller, JN Galgiani, MS Bartlett, A Espinel-Ingroff, ... Clinical Infectious Diseases 24 (2), 235-247, 1997 | 1011 | 1997 |
| Coccidioidomycosis JN Galgiani, NM Ampel, JE Blair, A Catanzaro, RH Johnson, DA Stevens, ... Clinical Infectious Diseases 41 (9), 1217-1223, 2005 | 781 | 2005 |
| The role of understaffing in central venous catheter-associated bloodstream infection SK Fridkin, SM Pear, TH Williamson, JN Galgiani, WR Jarvis Infection Control & Hospital Epidemiology 17 (3), 150-158, 1996 | 673 | 1996 |
| NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis DW Denning, JY Lee, JS Hostetler, P Pappas, CA Kauffman, ... The American journal of medicine 97 (2), 135-144, 1994 | 588 | 1994 |
| An insight into the antifungal pipeline: selected new molecules and beyond L Ostrosky-Zeichner, A Casadevall, JN Galgiani, FC Odds, JH Rex Nature reviews Drug discovery 9 (9), 719-727, 2010 | 514 | 2010 |
| 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis JN Galgiani, NM Ampel, JE Blair, A Catanzaro, F Geertsma, SE Hoover, ... Clinical Infectious Diseases 63 (6), e112-e146, 2016 | 479 | 2016 |
| Practice guidelines for the treatment of coccidioidomycosis JN Galgiani, NM Ampel, A Catanzaro, RH Johnson, DA Stevens, ... Clinical Infectious Diseases 30 (4), 658-661, 2000 | 364 | 2000 |
| Antifungal susceptibility testing JH Rex, MA Pfaller, MG Rinaldi, A Polak, JN Galgiani Clinical microbiology reviews 6 (4), 367-381, 1993 | 364 | 1993 |
| Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives TJ Sharpton, JE Stajich, SD Rounsley, MJ Gardner, JR Wortman, ... Genome research 19 (10), 1722-1731, 2009 | 357 | 2009 |
| Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: a randomized, double-blind trial JN Galgiani, A Catanzaro, GA Cloud, RH Johnson, PL Williams, LF Mirels, ... Annals of Internal Medicine 133 (9), 676-686, 2000 | 353 | 2000 |
| Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests A Espinel-Ingroff, CW Kish Jr, TM Kerkering, RA Fromtling, K Bartizal, ... Journal of Clinical Microbiology 30 (12), 3138-3145, 1992 | 302 | 1992 |
| Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis C Nguyen, BM Barker, S Hoover, DE Nix, NM Ampel, JA Frelinger, ... Clinical microbiology reviews 26 (3), 505-525, 2013 | 296 | 2013 |
| Coccidioidomycosis as a common cause of community-acquired pneumonia L Valdivia, D Nix, M Wright, E Lindberg, T Fagan, D Lieberman, ... Emerging infectious diseases 12 (6), 958, 2006 | 295 | 2006 |
| Coccidioidomycosis TM Chiller, JN Galgiani, DA Stevens Infectious Disease Clinics 17 (1), 41-57, 2003 | 292 | 2003 |
| Decrease in Nosocomial Clostridium difficile–Associated Diarrhea by Restricting Clindamycin Use SM Pear, TH Williamson, KM Bettin, DN Gerding, JN Galgiani Annals of Internal Medicine 120 (4), 272-277, 1994 | 285 | 1994 |
| Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients DG Fish, NM AMPEL, JN GALGIANI, CL DOLS, PC KELLY, ... Medicine 69 (6), 384-391, 1990 | 274 | 1990 |
| Detection of amphotericin B-resistant Candida isolates in a broth-based system JH Rex, CR Cooper Jr, WG Merz, JN Galgiani, EJ Anaissie Antimicrobial agents and chemotherapy 39 (4), 906-909, 1995 | 272 | 1995 |
| High-dose ketoconazole therapy and adrenal and testicular function in humans A Pont, JR Graybill, PC Craven, JN Galgiani, WE Dismukes, RE Reitz, ... Archives of Internal Medicine 144 (11), 2150-2153, 1984 | 259 | 1984 |
| Collaborative investigation of variables in susceptibility testing of yeasts MA Pfaller, MG Rinaldi, JN Galgiani, MS Bartlett, BA Body, ... Antimicrobial Agents and Chemotherapy 34 (9), 1648-1654, 1990 | 252 | 1990 |
| Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis EP Sampaio, AP Hsu, J Pechacek, HI Bax, DL Dias, ML Paulson, ... Journal of allergy and clinical immunology 131 (6), 1624-1634. e17, 2013 | 248 | 2013 |
